Sakashita and colleagues showed that the absence of PLAP-1 could inhibit high-fat diet-induced metabolic syndrome and bone resorption in vivo, and adipocyte differentiation resulting in an extracellular matrix change. The gene discussed is ASPN; the disease is metabolic syndrome.